Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Parathyroid Glands00:59

The Parathyroid Glands

The two pairs of parathyroid glands embedded within the posterior surface of the thyroid gland are restricted by a dense capsule around them. These glands comprise two distinct cell populations—parathyroid oxyphil and parathyroid principal cells- pivotal in calcium homeostasis.
Oxyphil cells, whose functions remain elusive, emerge during late puberty, adding a layer of complexity to the parathyroid gland's intricacies. In contrast, principal parathyroid cells undertake a vital role by producing...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Graves Disease II: Pathophysiology01:24

Graves Disease II: Pathophysiology

Graves’ disease is an autoimmune disorder characterized by the production of thyroid-stimulating immunoglobulins (TSI) that activate TSH receptors, leading to excessive synthesis and release of thyroid hormones (T3 and T4) and resulting in hyperthyroidism.Among all causes of hyperthyroidism, Graves’ disease is the most common and can happen at any age, though it is more frequent in women. It produces a hypermetabolic state with features such as weight loss, tachycardia, tremor, and heat...
Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Graves' Disease I: Introduction01:28

Graves' Disease I: Introduction

Graves' disease is an autoimmune disorder that causes hyperthyroidism, or overactivity of the thyroid gland. It results from autoantibodies called thyroid-stimulating immunoglobulins (TSIs), which bind to thyroid-stimulating hormone (TSH) receptors, leading to overstimulation of hormone production and a hypermetabolic state.EtiologyAlthough considered idiopathic, Graves’ disease has well-established contributing factors. There is a strong genetic component, with increased prevalence in...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The clinical utility of functional testing in fibroblasts to diagnose primary mitochondrial disease.

medRxiv : the preprint server for health sciences·2026
Same author

Gaucher Disease Treated With Lentiviral-Mediated Gene Therapy: First Case.

Journal of inherited metabolic disease·2026
Same author

Treatment goals for adults with early treated PKU should be determined by evidence-based shared decision making between patients and their medical team.

Orphanet journal of rare diseases·2026
Same author

End-Stage Ankle Osteoarthritis: Exploring the Precedent Causes and Time Course of Joint Degeneration.

JB & JS open access·2026
Same author

Biochemical, Clinical, and Functional Characterization of a Rare c.-106C>A Promoter Region Variant in Late-Onset Ornithine Transcarbamylase Deficiency: A Multifamily Case Series.

JIMD reports·2026
Same author

Effect of long-term sepiapterin treatment on dietary phenylalanine tolerance in patients with phenylketonuria: Interim results from the phase 3 APHENITY Extension Study.

Genetics in medicine : official journal of the American College of Medical Genetics·2026
Same journal

Causal Association Between Thyroid Function and Myeloproliferative Disease: A Two-Sample Mendelian Randomization Study.

International journal of endocrinology·2026
Same journal

The Role of Lipid Disorders in Cardiovascular Mortality Among Saudis: A Review Perspective.

International journal of endocrinology·2026
Same journal

A Novel Sarcopenia Screening Score Based on Thyroid Function Parameters in Euthyroid Middle-Aged and Elderly Chinese Adults.

International journal of endocrinology·2026
Same journal

Repurposing the Antibiotic Tigecycline to Inhibit Tumor Growth and Hormone Secretion in Somatotroph Pituitary Neuroendocrine Tumors.

International journal of endocrinology·2026
Same journal

Deletion of miR-122-5p Exacerbated Hyperthyroidism-Induced Liver Injury by Regulating Ferroptosis.

International journal of endocrinology·2026
Same journal

RETRACTION: Antidiabetic Activity of <i>Vinca rosea</i> Extracts in Alloxan-Induced Diabetic Rats.

International journal of endocrinology·2026
See all related articles

Related Experiment Video

Updated: May 31, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Primary hyperparathyroidism: an overview.

Jessica Mackenzie-Feder1, Sandra Sirrs, Donald Anderson

  • 1Division of Endocrinology and Metabolism, Department of Medicine, University of British Columbia, Vancouver, BC, Canada V5Z 1M9.

International Journal of Endocrinology
|July 13, 2011
PubMed
Summary
This summary is machine-generated.

Primary hyperparathyroidism, a common endocrine disorder, requires prompt recognition and treatment to reduce patient morbidity and mortality. This review covers its physiology, genetics, diagnosis, and management options.

More Related Videos

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Related Experiment Videos

Last Updated: May 31, 2026

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging
07:12

Establishment of a Simple and Effective Rat Model for Intraoperative Parathyroid Gland Imaging

Published on: August 17, 2022

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy
03:57

Generation of Hypoparathyroid Rats via Carbon-Nanoparticle-Assisted Parathyroidectomy

Published on: July 14, 2023

Area of Science:

  • Endocrinology
  • Calcium Homeostasis
  • Metabolic Bone Disease

Background:

  • Primary hyperparathyroidism (PHPT) affects 0.3% of the general population.
  • Early diagnosis and intervention are crucial for reducing PHPT-related morbidity and mortality.
  • PHPT management requires understanding calcium homeostasis and parathyroid hormone (PTH) regulation.

Purpose of the Study:

  • To provide a comprehensive review of primary hyperparathyroidism.
  • To discuss the physiology, genetics, etiology, and clinical presentation of PHPT.
  • To outline current and emerging diagnostic and therapeutic strategies for PHPT.

Main Methods:

  • Review of basic calcium homeostasis physiology.
  • Examination of genetic associations and common etiologies of PHPT.
  • Discussion of diagnostic modalities including PTH measurement and imaging.
  • Overview of surgical and medical management options, including bisphosphonates and calcimimetics.

Main Results:

  • PHPT is a prevalent condition with significant health implications.
  • Accurate diagnosis relies on understanding calcium-parathyroid hormone dynamics.
  • Both surgical and medical treatments, including bisphosphonates and calcimimetics, are effective.
  • Emerging trends in PTH detection and parathyroid imaging are improving diagnostic capabilities.

Conclusions:

  • Primary hyperparathyroidism necessitates timely diagnosis and management by healthcare professionals.
  • A thorough understanding of calcium homeostasis and PHPT pathophysiology guides effective treatment.
  • Current therapeutic options, including bisphosphonates and calcimimetics, offer viable management strategies.